Papaverine drug data and news

Papaverine drug data, resources, and news articles (when available). Onconews.org provides news on cancer research. This section, which includes profiles on medicines that may or not be cancer-related is in beta form. If things run smoothly we will be releasing a new format late in the summer of 2006.

Generic name Papaverine
Brand Names/Synonyms Alapav; Artegodan; Cardiospan; Cardoverina; Cepaverin; Cerebid; Cerespan; Chlorhydrate de Papaverine; Delapav; Dilaves; Dispamil; Drapavel; Durapav; Dynovas; Forpavin; Genabid; HSDB 3147; Myobid; Optenyl; PAPAVERINE; Pameion; Pamelon; Panergon; Pap H; Papacon; Papalease; Papanerin; Papanerin-Hcl; Papanerine; Papavarine Chlorhydrate; Papaverin; Papaverine Chlorohydrate; Papaverine Hcl; Papaverine Hydrochloride; Papaverine Monohydrochloride; Papaverine, Hydrochloride; Papaverinium Chloride; Papaversan; Papital T.R.; Paptial T.R.; Pavabid; Pavabid Hp; Pavacap; Pavacels; Pavacen; Pavacot; Pavadel; Pavagen; Pavakey; Pavarine; Pavased; Pavatest; Pavatine; Pavatym; Paverolan; Paveron; Pavnell; Qua Bid; Ro-Papav; Robaxapap; Spasmo-Nit; Therapav; Vasal; Vaso-Pav; Vasospan
Indication Impotence
Sponsored links
Description Not Available
Pharmacology Papaverine is a nonxanthine phosphodiesterase inhibitor for the relief of cerebral and peripheral ischemia associated with arterial spasm and myocardial ischemia complicated by arrhythmias. The main actions of Papaverine are exerted on cardiac and smooth muscle. Like qathidine, Papaverine acts directly on the heart muscle to depress conduction and prolong the refractory period. Papaverine relaxes various smooth muscles. This relaxation may be prominent if spasm exists. The muscle cell is not paralyzed by Papaverine and still responds to drugs and other stimuli causing contraction. The antispasmodic effect is a direct one, and unrelated to muscle innervation. Papaverine is practically devoid of effects on the central nervous system. Papaverine relaxes the smooth musculature of the larger blood vessels, especially coronary, systemic peripheral, and pulmonary arteries.
Mechanism Of Action Perhaps by its direct vasodilating action on cerebral blood vessels, Papaverine increases cerebral blood flow and decreases cerebral vascular resistance in normal subjects; oxygen consumption is unaltered. These effects may explain the benefit reported from the drug in cerebral vascular encephalopathy.
Papaverine News
(When available)

Love’sa step ahead of MS  Apr 24, 2006
Injectable medications include papaverine and alprostadil. Surgical implantation of a mechanical device (called a penile prosthesis) may help some men. ... - New Straits Times,

Vanilla's Value  Apr 25, 2006
...of Ldopa (L-doxyphenylalamina) used in the treatment of Parkinson’s disease, methyl-dopa (anti-hypertensive and tranquilising drug), papaverine (used in ... - Newindpress (subscription),

Dosage Forms LIQUID
Drug_Category Vasodilator Agents; Vasodilator Agents; ATC:A03AD01; ATC:G04BE02
Absorption Not Available
Interactions -->Interactions for Papaverine:

No information provided.

 

Toxicity Not Available
Organisms Affected Humans and other mammals
Chemical IUPAC Name 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-isoquinoline
Chemical Formula C20H21NO4
Molecular Weight 339.385 g/mol
Smiles String COC1=C(C=C(C=C1)CC2=NC=CC3=CC(=C(C=C32)OC)OC)OC
Melting Point Not Available
Water Solubility Not Available
State Solid
LogP/Hphobicity 3.72
Isoelectric Point Not Available
Biotransformation Not Available
Half Life 0.5-2 hours
Protein Binding [%] ~90%
RxList Link RXlist
Sponsored links
Drug Reference http://www.drugs.com/cons/Papaverine.html
http://www.rxlist.com/cgi/generic/papaverine.htm
Drug Type Approved Drug
Accession No APRD00628
CAS Registry Number 61-25-6
KEGG Compound ID Not Available
PubChem ID SID:65854
PharmGKB ID PA450779
SwissProt ID Not Available
GenBank ID Not Available
Drug ID Number [DIN] 9881

Home | About | Cancers | Treatment | Medications
Copyright onconews.org 2005.
All Rights Reserved.
Google
 
Web onconews.org